More recently, radiomics has been used to identify brain abscess from cystic gliomas [13], predict the molecular subtypes of HGGs (such as IDH [14, 15] and MGMT [16] status), assess the antiangiogenic treatment response of recurrent glioblastomas (GBMs) [17], and stratify the risk of patients with GBMs [18]. Here, MGMT is linked to glioblastoma.